The characteristic changes of GLP-1 face include 4,5 : Facial volume loss, particularly in the midface Periocular hollowing and periorbital volume depletion Dermal thinning with loss of collagen and elastin fibers Decreased skin elasticity leading to redundant skin folds Accelerated appearance of aging As a result of these facial changes, GLP-1 agonist medications can result in an older, haggard and tired looking appearance
High uptake with no discounts would lead to an annual cost equivalent to more than $US1 trillion ($1.5 trillion)
Affected women suffer from insulin resistance and present with an intense stress response
The side effects of Rybelsus are similar to those of other injectable GLP-1s
Acting on GLP-1 receptors in the brain , directly influencing appetite centers and potentially reducing cravings
Consumers describe feeling lighter but not smaller, seeing physical change but not trusting its permanence, and hesitating to invest in wardrobes before weight loss stabilizes